Non-Small Cell Lung Cancer Market: Impact of Molecular Testing and...

toegevoegd een audio Other

2026-10-27 18:54:36 - Translate -

Non-Small Cell Lung Cancer Market: Impact of Molecular Testing and Biomarker-Based Therapies

Valued at USD 38.88 billion in 2025, the non-small cell lung cancer market is projected to reach USD 42.64 billion in 2026 and USD 129.88 billion by 2034, growing at a CAGR of 14.3% during the forecast period 2026–2034. Expansion is propelled by a fast-changing treatment landscape in which targeted therapy and immunotherapy are improving survival outcomes in advanced and metastatic...

0 Reacties 0 aandelen 61 Views 0 voorbeeld